-
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIBIB Specific Interests and Guidance in RFA-NS-23-006 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis -
- Contract/Tender
- Posted 2 years ago
Notice of Request for Proposals (RFP), Solicitation 75N91023R00024: PREVENT Cancer Preclinical Drug Development Program
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Termination for PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction to Application Budget for PAR-23-050, "Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional)"
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIBIBs Withdrawal form Participation in RFA-HG-21-041 New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional).
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIBIB's Participation in PAR-22-181, " NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIBIB Specific Interests and Guidance in RFA-NS-23-007 "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
at National Institutes of Health in États-Unis